Browsing Tag: Featured

Genetic “Ageotypes” predict health as we age

Stanford’s Michael Snyder has categorized how humans age into different classes called “ageotypes”: metabolic, immune, hepatic and nephrotic. 43 healthy men and women between the ages of 34 and 68 were profiled, with extensive measurements of certain microbes and biological molecules, such as proteins, metabolites and lipids, taken at least five times over two years. […]

George Church on reversing aging | ApplySci @ Harvard

George Church again keynoted the ApplySci Boston conference, this year at Harvard Medical School on November 14, 2019. Click to view his groundbreaking talk on reversing aging. Join ApplySci at the 13th Wearable Tech + Digital Health + Neurotech Silicon Valley conference on February 11-12, 2020 at Quadrus Sand Hill Road.  Speakers include:  Zhenan Bao, Stanford – Vinod […]

Joe Wang on next-generation biosensors

Joseph Wang is the SAIC Endowed Chair professor, Chairman of the NanoEngineering Department and Director of the Center for Wearable Sensors at University of California, San Diego, and Editor-in-chief of the journal Electroanalysis. A prolific researcher with more than 1,200 papers and 100,000 citations, he recently developed an ultrasound patch to monitor blood pressure; self-propelled and targeted drug delivery; and continuous […]

AI for (much) earlier breast cancer detection – Constance Lehman

Connie Lehman — Professor, Radiology, Harvard Medical School; Chief of Breast Imaging, radiology, Massachusetts General Hospital; Co-director of AVON Breast Center, Radiology, Massachusetts General Hospital; and Director, Breast Imaging Research Center, Radiology, Massachusetts General Hospital spoke at ApplySci’s recent conference at Harvard Medical School. Click to listen to her talk on using AI to discover breast cancer 5 years […]

Invasive deep brain stimulation for alcoholism?

Stanford’s Casey Halpern and Allen Ho have used deep brain stimulation to target nucleus accumbens, thought to reduce impulsive behavior, to combat alcoholism in animal and pilot human studies. DBS is used in severe Parkinson’s disease and is not approved by the FDA for addiction. Infection and other complications are risks of this invasive surgery. ApplySci hopes that […]

AI – optimized glioblastoma chemotherapy

Pratik Shah, Gregory Yauney,  and MIT Media Lab researchers have developed an AI  model that could make glioblastoma chemotherapy regimens less toxic but still effective. It analyzes current regimens and iteratively adjusts doses to optimize treatment with the lowest possible potency and frequency toreduce tumor sizes. In simulated trials of 50 patients, the machine-learning model […]

Wrist wearable measures blood counts, bacteria, air particles

Rutgers scientists Mehdi Javanmard and Abbas Furniturewalla have developed a wrist wearable that can count particles, including blood cells, bacteria, and organic or inorganic air particles. Red blood cell counts can indicate internal bleeding. High or low white blood cell counts can indicate cancers, such as leukemia, or other illnesses. The plastic wristband includes a flexible circuit […]

Hydrogen peroxide sensor to determine effective chemotherapy

MIT’s Hadley Sikes has developed a sensor that determines whether cancer cells respond to a particular type of chemotherapy by detecting hydrogen peroxide inside human cells. The technology could help identify new cancer drugs that boost levels of hydrogen peroxide, which induces programmed cell death. The sensors could also be adapted to screen individual patients’ […]

Sensor could continuously monitor brain aneurysm treatment

Georgia Tech’s Woon-Hong Yeo has  developed a proof of concept, flexible, stretchable sensor that can continuously monitor hemodynamics when integrated with a stent like flow diverter after a brain aneurysm. Blood flow is measured using  capacitance changes. According to Pittsburgh professor Youngjae Chun, who collaborated with Yeo, “We have developed a highly stretchable, hyper-elastic flow diverter using a […]